167 related articles for article (PubMed ID: 24825564)
1. mTORC1 is involved in hypoxia-induced pulmonary hypertension through the activation of Notch3.
Wang W; Liu J; Ma A; Miao R; Jin Y; Zhang H; Xu K; Wang C; Wang J
J Cell Physiol; 2014 Dec; 229(12):2117-25. PubMed ID: 24825564
[TBL] [Abstract][Full Text] [Related]
2. Notch activation of Ca
Guo Q; Xu H; Yang X; Zhao D; Liu S; Sun X; Huang JA
Hypertens Res; 2017 Feb; 40(2):117-129. PubMed ID: 27581537
[TBL] [Abstract][Full Text] [Related]
3. mTOR-Notch3 signaling mediates pulmonary hypertension in hypoxia-exposed neonatal rats independent of changes in autophagy.
Ivanovska J; Shah S; Wong MJ; Kantores C; Jain A; Post M; Yeganeh B; Jankov RP
Pediatr Pulmonol; 2017 Nov; 52(11):1443-1454. PubMed ID: 28759157
[TBL] [Abstract][Full Text] [Related]
4. Notch3 signaling promotes the development of pulmonary arterial hypertension.
Li X; Zhang X; Leathers R; Makino A; Huang C; Parsa P; Macias J; Yuan JX; Jamieson SW; Thistlethwaite PA
Nat Med; 2009 Nov; 15(11):1289-97. PubMed ID: 19855400
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between the Akt/mTORC1 and NF-κB signaling pathways promotes hypoxia-induced pulmonary hypertension by increasing DPP4 expression in PASMCs.
Li Y; Yang L; Dong L; Yang ZW; Zhang J; Zhang SL; Niu MJ; Xia JW; Gong Y; Zhu N; Zhang XJ; Zhang YY; Wei XM; Zhang YZ; Zhang P; Li SQ
Acta Pharmacol Sin; 2019 Oct; 40(10):1322-1333. PubMed ID: 31316183
[TBL] [Abstract][Full Text] [Related]
6. Exosomes derived from mesenchymal stromal cells exert a therapeutic effect on hypoxia-induced pulmonary hypertension by modulating the YAP1/SPP1 signaling pathway.
Chen YX; Deng ZH; Xue-Gao ; Qiang-Du ; Juan-Yin ; Chen GH; Li JG; Zhao YM; Zhang HT; Zhang GX; Qian JX
Biomed Pharmacother; 2023 Dec; 168():115816. PubMed ID: 37918254
[TBL] [Abstract][Full Text] [Related]
7. Selective Tuberous Sclerosis Complex 1 Gene Deletion in Smooth Muscle Activates Mammalian Target of Rapamycin Signaling and Induces Pulmonary Hypertension.
Houssaini A; Abid S; Derumeaux G; Wan F; Parpaleix A; Rideau D; Marcos E; Kebe K; Czibik G; Sawaki D; Treins C; Dubois-Randé JL; Li Z; Amsellem V; Lipskaia L; Pende M; Adnot S
Am J Respir Cell Mol Biol; 2016 Sep; 55(3):352-67. PubMed ID: 26991739
[TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV attenuates hypoxia‑induced pulmonary vascular remodeling via the Notch signaling pathway.
Yao J; Fang X; Zhang C; Yang Y; Wang D; Chen Q; Zhong G
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236156
[TBL] [Abstract][Full Text] [Related]
9. A Critical Role of the mTOR/eIF2α Pathway in Hypoxia-Induced Pulmonary Hypertension.
Wang AP; Li XH; Yang YM; Li WQ; Zhang W; Hu CP; Zhang Z; Li YJ
PLoS One; 2015; 10(6):e0130806. PubMed ID: 26120832
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Notch3 prevents monocrotaline-induced pulmonary arterial hypertension.
Zhang Y; Xie X; Zhu Y; Liu L; Feng W; Pan Y; Zhai C; Ke R; Li S; Song Y; Fan Y; Fan F; Wang X; Li F; Li M
Exp Lung Res; 2015; 41(8):435-43. PubMed ID: 26317171
[TBL] [Abstract][Full Text] [Related]
11. RGS10 inhibits proliferation and migration of pulmonary arterial smooth muscle cell in pulmonary hypertension via AKT/mTORC1 signaling.
Hu S; Zhang Y; Qiu C; Li Y
Clin Exp Hypertens; 2023 Dec; 45(1):2271186. PubMed ID: 37879890
[No Abstract] [Full Text] [Related]
12. Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats.
Pena A; Kobir A; Goncharov D; Goda A; Kudryashova TV; Ray A; Vanderpool R; Baust J; Chang B; Mora AL; Gorcsan J; Goncharova EA
Am J Respir Cell Mol Biol; 2017 Nov; 57(5):615-625. PubMed ID: 28679058
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of Akt1, but not Akt2, attenuates the development of pulmonary hypertension.
Tang H; Chen J; Fraidenburg DR; Song S; Sysol JR; Drennan AR; Offermanns S; Ye RD; Bonini MG; Minshall RD; Garcia JG; Machado RF; Makino A; Yuan JX
Am J Physiol Lung Cell Mol Physiol; 2015 Jan; 308(2):L208-20. PubMed ID: 25416384
[TBL] [Abstract][Full Text] [Related]
14. Wnt5a attenuates hypoxia-induced pulmonary arteriolar remodeling and right ventricular hypertrophy in mice.
Jin Y; Wang W; Chai S; Liu J; Yang T; Wang J
Exp Biol Med (Maywood); 2015 Dec; 240(12):1742-51. PubMed ID: 25956683
[TBL] [Abstract][Full Text] [Related]
15. Exploration of the Notch3-HES5 signal pathway in monocrotaline-induced pulmonary hypertension using rat model.
Chen X; Zhou W; Hu Q; Huang L
Congenit Heart Dis; 2019 May; 14(3):396-402. PubMed ID: 30811836
[TBL] [Abstract][Full Text] [Related]
16. Notch Activation of Ca(2+) Signaling in the Development of Hypoxic Pulmonary Vasoconstriction and Pulmonary Hypertension.
Smith KA; Voiriot G; Tang H; Fraidenburg DR; Song S; Yamamura H; Yamamura A; Guo Q; Wan J; Pohl NM; Tauseef M; Bodmer R; Ocorr K; Thistlethwaite PA; Haddad GG; Powell FL; Makino A; Mehta D; Yuan JX
Am J Respir Cell Mol Biol; 2015 Sep; 53(3):355-67. PubMed ID: 25569851
[TBL] [Abstract][Full Text] [Related]
17. Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension.
Goncharov DA; Kudryashova TV; Ziai H; Ihida-Stansbury K; DeLisser H; Krymskaya VP; Tuder RM; Kawut SM; Goncharova EA
Circulation; 2014 Feb; 129(8):864-74. PubMed ID: 24270265
[TBL] [Abstract][Full Text] [Related]
18. Soluble JAGGED1 inhibits pulmonary hypertension by attenuating notch signaling.
Xiao Y; Gong D; Wang W
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2733-9. PubMed ID: 24072692
[TBL] [Abstract][Full Text] [Related]
19. Involvement of CapG in proliferation and apoptosis of pulmonary arterial smooth muscle cells and in hypoxia-induced pulmonary hypertension rat model.
Xu X; Hu H; Wang X; Ye W; Su H; Hu Y; Dong L; Zhang R; Ying K
Exp Lung Res; 2016 Apr; 42(3):142-53. PubMed ID: 27093378
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension.
Aghamohammadzadeh R; Zhang YY; Stephens TE; Arons E; Zaman P; Polach KJ; Matar M; Yung LM; Yu PB; Bowman FP; Opotowsky AR; Waxman AB; Loscalzo J; Leopold JA; Maron BA
FASEB J; 2016 Jul; 30(7):2511-27. PubMed ID: 27006450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
